QQQ ()
DIA ()
SPY ()
TLT ()
GLD ()
$ na
-- x --
-- x --
-- - --
-- - --
--
na
--
--
--
TBD
--
-- (--)
--
TBD --
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
No Data found
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 rbc-capital-reiterates-outperform-on-corbus-pharmaceuticals-maintains-82-price-target

RBC Capital analyst Brian Abrahams reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and maintains $82 price...

 rbc-capital-reiterates-outperform-on-corbus-pharmaceuticals-maintains-82-price-target

RBC Capital analyst Brian Abrahams reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and maintains $82 price...

 oppenheimer-maintains-outperform-on-corbus-pharmaceuticals-raises-price-target-to-88

Oppenheimer analyst Jeff Jones maintains Corbus Pharmaceuticals (NASDAQ:CRBP) with a Outperform and raises the price target ...

 hc-wainwright--co-reiterates-buy-on-corbus-pharmaceuticals-maintains-80-price-target

HC Wainwright & Co. analyst Andrew Fein reiterates Corbus Pharmaceuticals (NASDAQ:CRBP) with a Buy and maintains $80 pri...

 corbus-pharmaceuticals-q2-eps-090-beats-126-estimate

Corbus Pharmaceuticals (NASDAQ:CRBP) reported quarterly losses of $(0.90) per share which beat the analyst consensus estimate o...

 genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

 genedx-leads-russell-2000-this-year-as-it-shifts-to-more-comprehensive-genetic-testing-corrected

GeneDx Holdings Corp. (NASDAQ: WGS) has soared 1,101% this year, attributed to its mix shift towards exome/genome testing and r...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION